ImmunoPrecise Antibodies Ltd (IPA)
0.4001
-0.02
(-4.76%)
USD |
NASDAQ |
Dec 20, 16:00
0.4014
0.00 (0.00%)
After-Hours: 20:00
ImmunoPrecise Antibodies Enterprise Value: 12.11M for Dec. 20, 2024
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Aurinia Pharmaceuticals Inc | 944.16M |
| Edesa Biotech Inc | 4.684M |
| Lexaria Bioscience Corp | 31.99M |
| Xenon Pharmaceuticals Inc | 2.296B |
| ESSA Pharma Inc | -55.74M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -1.870M |
| Revenue (Quarterly) | 4.486M |
| Total Expenses (Quarterly) | 6.550M |
| EPS Diluted (Quarterly) | -0.0659 |
| Gross Profit Margin (Quarterly) | 56.11% |
| Profit Margin (Quarterly) | -41.68% |
| Earnings Yield | -193.1% |
| Normalized Earnings Yield | -91.77 |